| 2-AG | 2-arachidonoylglycerol |
| 5-HTR | 5-hydroxytryptamine receptor |
| AA | Arachidonic acid |
| AEA | N-arachidonoyl-ethanolamine or anandamide |
| AEDs | Anti-epileptic drugs |
| CBD | Cannabidiol |
| CBDV | Cannabidivarin |
| Cys-LT | Cysteinyl leukotriene |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| CYP | Cytochrome P450 |
| EA | Ethanolamide |
| ECS | Endocannabinoid system |
| EET | Epoxyeicosatrienoic acid |
| ENT1 | Equilibrative nucleoside transporter |
| FAAH | Fatty acid amide hydrolase |
| FDA | Food and Drug Administration |
| GPR | G-protein coupled receptor |
| HETE | Hydroxyeicosatetraenoic acid |
| HPETE | 5-hydroperoxyeicosatetraenoic acid |
| IL-1β | Interleukin-1β |
| LOX | Lipoxygenase |
| LT | Leukotriene |
| MAGL | Monoacylglycerol lipase |
| mRNA | Messenger ribonucleic acid |
| miRNA | Micro ribonucleic acid |
| MRS | Magnetic Resonance Spectroscopy |
| PET | Positron Emission Tomography |
| PG | Prostaglandin |
| PGH2-G | Prostaglandin H2-glycerol ester |
| RNA | Ribonucleic acid |
| TGA | Therapeutic Goods Administration |
| TNF-α | Tumor necrosis factor-α |
| Δ9-THC or THC | Delta-9 tetrahydrocannabinol |
| TRPV | Transient Receptor Potential Vanilloid |
| TSPO | Translocator protein |
| VDAC | Voltage-dependent anion selective channel protein |
| WHO | World Health Organization |